You are on Trendlyne United States. Click here to go to India website or make United States as your default

Ceribell Inc. XNAS: CBLL

Ceribell Inc. Live Share Price Today, Share Analysis and Chart

14.84 0.35 (2.42%)

54.69% Fall from 52W High

615.7K XNAS Volume

High vol. this week

XNAS 17 Apr, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Ceribell Inc. is on 30 Apr 2025 for the purpose of CeriBell Inc Annual General Meeting for 2025 See details

Ceribell Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '24Dec '25Dec '265075100125Actual RevenueAvg. Estimate
Hit

Ceribell Inc.'s Revenue was higher than average estimate 1 time in past 1 year

EPS forecast

Current EPS
-3.4
Avg. Estimate
-1.7
Low Estimate
-1.9
High Estimate
-1.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 50.1% in FY25

Consensus Recommendation

5 ANALYST Recommendations
STRONG BUY

Created with Highcharts 7.2.21Buy4Strong Buy

The consensus recommendation from 5 analysts for Ceribell Inc. is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Ceribell Inc. Stock Analysis

Ceribell Inc. stock analysis with key metrics, changes, and trends.

Ceribell Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$65.44 M44.71%positive

Annual Revenue rose 44.71%, in the last year to $65.44 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$40.46 M37.3%negative

Annual Net Profit fell 37.3% in the last year to $40.46 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Stock Price$14.84-1.07%positive

Stock Price rose 1.07% outperformed its sector by 0.68% in the past week.

Quarterly Revenue$18.53 M41.15%positive

Quarterly Revenue rose 41.15% YoY to $18.53 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$12.58 M51.99%negative

Quarterly Net profit fell 51.99% YoY to $12.58 M. Its sector's average net profit growth YoY for the quarter was 32.89%.

Debt to Equity Ratio0.11-positive

Debt to Equity Ratio of 0.11 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-102.53 %-102.53%negative

Return on Equity(ROE) for the last financial year was -102.53%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding28.02 %0.87%positive

Mutual Fund Holding increased by 0.87% in the last quarter to 28.02.

Interest Coverage Ratio-19.31-negative

Interest Coverage Ratio is -19.31, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding64.38 %0.01%positive

Institutional Holding increased by 0.01% in the last quarter to 64.38.

VIEW LESS


Loading data..

Ceribell Inc. - Company Profile

What does Ceribell Inc. do?

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Ceribell Inc. Management structure

All Gross Remunerations are in USD
Dr. Xingjuan Chao, PhD
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Mr. Scott Blumberg
Chief Financial Officer
-
2024
Gross Remuneration
Year
Mr. David Foehr
Principal Accounting Officer and Senior Vice President, Finance
-
2024
Gross Remuneration
Year

Ceribell Inc. Board of directors

All Gross Remunerations are in USD
Mr. Joseph Michael Taylor
Independent Director
-
2024
Gross Remuneration
Year
Mr. William W. Burke
Independent Director
-
2024
Gross Remuneration
Year
Ms. Juliet Tammenoms Bakker
Independent Director
-
2024
Gross Remuneration
Year
Ms. Rebecca Robertson
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. Lucian Iancovici, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Dr. Xingjuan Chao, PhD
President, Chief Executive Officer and Director
-
2024
Gross Remuneration
Year

Ceribell Inc. FAQ

How is Ceribell Inc. today?
Ceribell Inc. today is trading in the green, and is up by 2.42% at 14.84.
Ceribell Inc. is currently trading up 2.42% on an intraday basis. In the past week the stock fell -1.07%. stock has been down -29.47% in the past quarter and fell None% in the past year. You can view this in the overview section.